Patents by Inventor Michael Donald Farley

Michael Donald Farley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030190376
    Abstract: An anti-aromatase nutraceutical or pharmaceutical composition, consisting of a capsule or dose to contain
    Type: Application
    Filed: January 13, 2003
    Publication date: October 9, 2003
    Inventor: Michael Donald Farley
  • Patent number: 6607755
    Abstract: An anti-aromatase pharmaceutical composition is provided containing nettle root extract in the range of about 275 to 350 mg, pumpkin seed oil in the range of about 150 to 205 mg, Pygeum Africanum or Prunus africana bark extract, standardized to contain at least 12 to 15% of total sterols, in the range of about 20 to 40 mg, and Chrysin in the range of 475 to 550 mg. This pharmaceutical composition assists in the treatment of benign prostate hyperthropy and breast cancer.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: August 19, 2003
    Inventor: Michael Donald Farley
  • Publication number: 20030133945
    Abstract: The present invention is a food supplement for a human body's natural immune function, formed from natural occurring substances in the form of a broth.
    Type: Application
    Filed: January 11, 2002
    Publication date: July 17, 2003
    Inventor: Michael Donald Farley
  • Publication number: 20030099728
    Abstract: An anti-aromatase pharmaceutical composition, consisting of in capsule or dose to contain
    Type: Application
    Filed: June 21, 2001
    Publication date: May 29, 2003
    Inventor: Michael Donald Farley
  • Patent number: 6544564
    Abstract: An inventive and proprietary formula to enhance the body's natural immune function against viral and infectious diseases and cancer. The composition per unit dose in liquid or capsule gel caplets consists of: 200 to 600 mg. of Chrysin; 200 to 600 mg. of Colorius Versicolor PSK; 50 to 150 mg. of 3,3′ Diindolylmethane DIM; 50 to 150 mg. of Resveratrol 25%; 50 to 150 mg. Turmeric Extract 95%; 40 to 140 mg. Green Tea Extract 95%; 20 to 80 mg. of Quercitin Dihydrate 99%; and 15 to 75 mg. of Phosphatidyl Choline 50% Advantageously, each dose unit preferably includes 25 mg. to about 150 mgs. of Myricetin.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: April 8, 2003
    Inventor: Michael Donald Farley